The Gram-negative human pathogen Neisseria gonorrhoeae has progressively developed 25 resistance to antibiotic monotherapies, and recent failures of dual-drug therapy have heightened 26 concerns that strains resistant to all available antibiotics will begin circulating globally. 27
INTRODUCTION 47 7
Cultures were removed from the plate, harvested by centrifugation (1 min, 10,000 x g), washed 139 twice with pre-warmed cGCBL and restarted in a new pre-warmed 24-well plate in fresh 140 medium with or without continuation of DTZ treatment for an additional 12.5 h. In all 141 experiments, growth was assayed in triplicate for each condition. 142 143 Antibiotic susceptibility testing. For disk diffusion measurements, N. gonorrhoeae strains 144 (listed in Table 1 ) were cultured overnight on GCB plates, then in liquid culture for 3 h as 145 described above. Cultures were normalized to an optical density (A 540 ) of 0.3 in 2 ml cGCBL and 146 applied to GCB plates with a Dacron swab. Plates were placed at 37°C with 5% CO 2 for ~1 h to 147 dry prior to application of three 0.25-inch differentiation disks per plate (Hardy Diagnostics). To 148 each disk, 10 μl of a 10 mM DTZ stock solution was added, and plates were incubated overnight 149 at 37°C with 5% CO 2 . Following ~18 h of incubation, the radius of each zone of inhibition was 150 measured in duplicate for each of three disks using digital calipers. 151
Minimum inhibitory concentration (MIC) values were obtained using the agar dilution 152 method, as applied by the CDC gonococcal isolate surveillance program (GISP). Briefly, 153 gonococci were streaked from frozen stocks to GCB plates, cultured overnight at 37°C with 5% 154 CO 2 , passaged onto new GCB plates and cultured as above for ~18 h. Bacteria were swabbed 155 into cGCBL, adjusted to an A 540 value of 0.1, and 5 μL of adjusted suspension (for each tested 156 strain) was spotted in triplicate on plates with various concentrations of antibiotics. For testing of8 DTZ was tested in the range of 8-256 μg/ml. Assays were performed in duplicate only due to 161 limiting amounts of available DTZ stock. 162 163 Enzyme activity assay. Purified His-LdcA (25 nM, ~100 ng) was added to reaction buffer 164 containing 10 mM Tris-HCl pH 8.0 and allowed to incubate with either 10 μl of 30% DMSO 165 (vehicle control) or 10 μl of 10 mM DTZ (1 mM final concentration), at 37°C for 1 h with 166 constant agitation. A control reaction was performed in parallel with His-LdcA absent. At the 167 conclusion of the pre-incubation step, ~8x10 3 CPM of [ 3 H]-labeled GlcNAc-anhMurNAc-168 tetrapeptide PG monomer was added to each reaction to reach a final volume of 100 μl. 169
Incubation was continued for 1 h at 37°C with constant agitation. At the conclusion of 170 incubation, reactions were boiled for 15 min and stored at -20°C. The entire volume of each 171 reaction was separated by reversed-phase HPLC on a Prevail C 18 column (5 μm pore, 250 x 4.6 172 mm) (Grace Vydac) operating at room temperature, at a flow rate of 1 ml/min on a linear 173 gradient of 16-52% eluent (25% ACN + 0.05% TFA) in a mobile phase of 0.05% TFA over 30 174 minutes (yielding a 4-13% ACN gradient). One-minute fractions were collected and measured by 175 liquid scintillation counting. Additional information regarding His-LdcA enzyme and 176 tetrapeptide monomer substrate purifications has been described previously (22) . 177 9 (DMEM with 4.5 g/l glucose, 2 mM L-glutamine, 10% heat-inactivated FBS) at ~3.4 x 10 6 184 cells/ml in 1 ml volumes in a 24 well tissue-culture treated plate (Costar). N. gonorrhoeae strain 185 MS11 (p+, Opa-) was grown overnight on GCB agar containing 75 μg/ml streptomycin, swabbed 186 into cGCBL, and 2 x A 540 equivalents were harvested, washed in PBS and suspended in 1 ml 187 antibiotic-free medium. L. gasseri strain 33323 was grown overnight on MRS agar, swabbed into 188 MRS broth, and 10 x A 540 equivalents were harvested, washed in PBS and suspended in 1 ml 189 antibiotic-free medium. gonorrhoeae respond in the same way to DTZ, then treatment would be predicted to have no 214 significant impact until cultures reached stationary phase. Instead, we observed an immediate 215 alteration of growth in the 100 μM treatment and early growth arrests for treatments from 50 μM 216 down to 20 μM ( Fig 1A) . While 20 and 30 μM treatments stopped growth but remained at a 217 consistent A 540 value, treatments of 40, 50, and 100 μM caused declines in A 540 over time. These 218 declines in culture density could be due in part to the stress-induced autolytic behavior that N. 219 gonorrhoeae exhibits in culture (37, 38). To determine if DTZ treatment later in log-phase 220 growth had any effect, we treated cultures at 4.5 hours of growth, just before cultures should 221 reach their peak density. Again, nearly immediate growth arrest and gradual reduction in culture 222 density occurred with 50 and 100 μM treatments (Fig 1B) . Unlike with E. coli, it appears that 223 treatment during N. gonorrhoeae growth has effects well before stationary phase and cultures do 224 not readily recover with more time. 225
Since the initial published experiments with E. coli involved cultures with DTZ present 226 throughout growth, we attempted to start cultures of N. gonorrhoeae directly from overnight 227 plates (a common culturing method for this organism) into medium with DTZ present to monitor 228 growth initiation. Early attempts at starting growth in concentrations similar to those used formid-log treatment resulted in complete failure to grow. When substantially lower concentrations 230 were used, we found that 2 μM was sufficient to prevent growth, while cultures with 1 μM DTZ 231 present were able to grow normally after an approximately 2 h lag (compared to vehicle-only 232 control) (Fig 1C) . It should be noted that this method of treatment was the most variable for 233 reasons that remain incompletely understood. In one experiment, very limited growth was seen 234 in 2 μM DTZ, while in two other experiments 1 μM or even 500 nM completely attenuated 235 growth. The representative experiment selected here should therefore be considered a 236 conservative representative of similar experiments. Lastly, we wanted to know how our 237 observations on the strict pathogen N. gonorrhoeae would compare to a commensal Neisseria 238 species. Following DTZ addition in mid-log phase, N. lactamica growth was immediately 239 arrested and A 540 began to decline following a treatment as low as 10 μM (Fig 1D) have an additional activity on PG crosslinks (endopeptidase activity) (22). To examine the ability 253 of DTZ to inhibit Ng-LdcA, we treated purified enzyme with 1 mM DTZ, then measured the 254 ability of Ng-LdcA (in the continued presence of DTZ) to process tetrapeptide PG monomer to 255 tripeptide PG monomer. We observed that the presence of DTZ did not significantly inhibit Ng-256
LdcA activity on PG monomer (Fig 2A) . Diluting LdcA in ten-fold steps (to assure enzyme was 257 not present in excess) reduced enzyme activity but did not reveal any DTZ inhibitory activity 258 (data not shown). 259
When DTZ was initially tested on E. coli, growth inhibition could be relieved by 260 overexpressing LdcA from a plasmid, suggesting that DTZ was capable of targeting LdcA 261 activity in vivo as well as in vitro. Since Ng-LdcA activity was not reduced by DTZ in vitro, we 262 wanted to know if the inhibitory effect of DTZ on N. gonorrhoeae growth was dependent on the 263 presence of LdcA. Disk diffusion assays were performed to compare the sensitivity of wild-type 264 N. gonorrhoeae to isogenic ldcA deletion and complementation strains. No significant difference 265 in sensitivity to DTZ was observed when ldcA was absent or when ldcA was induced from a 266 complementation site (Fig 2B) . In liquid culture, sensitivity is unchanged between WT and a 267 strain with an ldcA active site mutation when 10 or 100 μM DTZ is added during mid-log 268 growth, while a strain with inactive LdcA is more sensitive than WT to 50 μM DTZ (Fig S1) . 269
The inability of DTZ to inhibit purified Ng-LdcA activity or for deletion of ldcA to significantly 270 reduce the suppressive effect of DTZ on N. gonorrhoeae growth, leads us to conclude that LdcA 271
is not the primary target of DTZ in this organism. gonorrhoeae isolates revealed that MS11 exhibits a higher level of resistance than other well-276 studied laboratory strains (Fig 2B) . MS11 possesses higher resistance to numerous antimicrobials 277 in part due to expression differences of the MtrC-MtrD-MtrE efflux pump system in MS11 (39). 278
To determine if the Mtr efflux pump system was responsible for increasing resistance to DTZ, 279
we determined minimum inhibitory concentration (MIC) values for DTZ in both wild-type MS11 280
and an isogenic mtrD mutant (mtrD::kan) ( Table 2 ). We determined the MIC of DTZ to be 128 281 μg/mL for MS11, and 32 μg/mL for the mtrD mutant, indicating that DTZ is a substrate for Mtr-282 dependent efflux. The MIC value for MS11 places DTZ near the MIC determined for Penicillin 283 G (64 μg/mL), but with a much higher MIC than Erythromycin (1-2 μg/mL) or Ceftriaxone (0.25 284 μg/mL). However, among the antibiotics tested, DTZ was the least susceptible to Mtr-dependent 285 efflux, with only a 4-fold difference in MIC (as compared to 6-to 14-fold for other antibiotics). μg/mL DTZ, respectively, and 2) by growing these same strains on plates with 64 or 16 μg/mL 300 DTZ, respectively, and passaging onto plates at the MIC (128 or 32 μg/mL DTZ, respectively). 301
While strains grew below the MIC, no resistant colonies were obtained above the MIC from 302 either method (data not shown). DTZ is therefore likely acting on a target for which escape 303 mutations are extremely rare. Taken together, DTZ possesses several favorable properties for 304 further exploration as a therapeutic against N. gonorrhoeae, including less susceptibility to efflux 305 than currently used compounds, no exceptional resistance among current multi-drug resistant 306 strains, and undetectable levels of spontaneous resistance generation. 307 308 DTZ has bacteriostatic action against N. gonorrhoeae. Compounds in the β-lactam family, 309 which target cell wall metabolism, are among the antibiotics considered bacteriocidal, or having 310 an action that kills bacteria in culture. In contrast, agents that arrest bacterial growth or 311 replication in culture without an immediate killing effect are considered bacteriostatic. Examples 312 of bacteriostatic compounds include the macrolides, tetracyclines, and aminoglycosides, which 313 block bacterial protein synthesis. To understand how DTZ is acting on N. gonorrhoeae, we grew 314 bacteria in culture to mid-log phase and treated with DTZ. Following a 2.5 h treatment period, 315 we removed cells from culture, washed with fresh medium and either returned DTZ to the 316 medium or allowed cultures to recover without antibiotics (Fig 3) . Cultures that were treated 317 with DTZ both before and after washing halted growth after initial treatment and then were 318 effectively prevented from restarting growth after the wash, as would be predicted from the 319 findings presented in Fig 1A and 1C . In control cultures not exposed to DTZ, some bacteria were 320 (Fig  340   4A) . Specifically, the 50 and 100 μM concentrations that noticeably inhibited N. gonorrhoeae 341 growth cause L. gasseri to reach higher final culture densities. When DTZ was added during late 342 log phase, no change in growth was observed even with a 250 μM dose (Fig 4B) 
